Agilent Technologies (A) has announced its intention to acquire Biocare Medical for $950 million, a move expected to expand its presence in the life sciences and diagnostics market.

Agilent Technologies announced its plan to acquire Biocare Medical for $950 million, a move aimed at expanding its pathology portfolio.

Agilent Technologies has announced the acquisition of Biocare Medical, a medical instruments manufacturer, for $950 million. This strategic move aims to expand Agilent's portfolio in the medical diagnostics sector.